FDA approves Cassipa for medication-assisted treatment for opioid dependence
Today, the FDA announced the approval of Cassipa, developed by Teva Pharmaceuticals for the maintenance treatment of opioid dependence.
Today, the FDA announced the approval of Cassipa, developed by Teva Pharmaceuticals for the maintenance treatment of opioid dependence.